摘要
目的：测定我国血液透析和腹膜透析的疾病经济负担,为建立合理的透析治疗费用支付范围和标准提供决策依据。方法：根据血透和腹透患者的年直接医疗费用、直接非医疗费用和间接费用计算经济负担。结果：血透和腹透患者的年总费用分别是98204元和84141元,其中直接医疗费用分别是80988元和76205元,直接非医疗费用分别是6014元和3522元,间接费用分别是11132元和4414元；医保部分每年为每位血透患者和腹透患者分别负担总费用的65．8％和72．0％。血透患者和腹透患者的负债率分别是8．2％和3．6％。结论：透析对患者和医保部门来说经济负担都是沉重的,需要多方面积极采取措施,控制费用,提高疗效。
Objective： This paper is to provide policy recommendation to establish rational reimbursement system of medical insurance on the payment of dialysis therapy through the study of disease burden. Method： Disease burden is composed on direct medical cost non-medical cost and indirect cost. Results： The total costs of hemodialysis and peritoneal dialysis were 98 204 RMB and 84 141RMB. The direct medical costs of hemodialysis and peritoneal dialysis were 80 988RMB and 76 205RMB per patient per year. The direct non-medical costs were 6 014 RMB and 3 522 RMB. The indirect costs were 11 132 RMB and 4 414RMB. The payment rate of medical insurance for hemodialysis and peritoneal dialysis were 65.8% and 72.0% of total costs per year. The debt rate of patient of hemodialysis and peritoneal dialysis were 8.2% and 3.6% respectively. Conclusion： A high burden of patients and medical insurance institution illustrated the necessitv to control the cost and improve their effect.
出处
《中国卫生资源》
2006年第2期68-69,共2页
Chinese Health Resources
基金
中国社会保险学会医疗保险分会资助项目国家软科学指导性项目
项目编号:2005DGQ4B124
